dorsaVi Limited (AU:DVL) has released an update.
dorsaVi Ltd has successfully completed a pivotal clinical study in collaboration with Norton Healthcare, utilizing its advanced wearable sensor technology to investigate spinal motion and movement patterns in surgeries. The two-year project was led by orthopaedic spine surgeon Dr. Steven Glassman and is expected to enhance dorsaVi’s product research while also contributing approximately A$100,000 in sponsored research support. The results, poised to reinforce dorsaVi’s market position, are anticipated to be published and presented in medical forums.
For further insights into AU:DVL stock, check out TipRanks’ Stock Analysis page.
